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Microbiological contamination of dialysate is an issue that
attracted attention since the 1990s. This is partly due to the exten-
sive use of sodium bicarbonate as a dialysate buffer, which helps
microbial proliferation, and also the use of high flux dialysers that
allow back filtration of microbial contaminants.1 Microbial con-
taminants most frequently found in dialysis water are bacteria
and their degradation products, such as endotoxins, peptidogly-
cans and bacterial DNA (bDNA). Fungi, viruses and protozoa can
also be encountered occasionally.2 Endotoxins are heat-stable
lipopolysaccharides (LPS) and the major cell wall components of
Gram-negative bacteria.3 The molecular mass of LPS ranges
between 2000 and 20,000 Da. LPS can be transferred through
membranes with large pore size by back filtration/diffusion from
the dialysis fluid to the blood compartment.4 If the dialyser mem-
brane is tight, bacteria are not able to pass from the dialysate com-
partment into the blood compartment. However, endotoxins, can
permeate and cause an inflammatory state.5
Exposure to microbial contaminants is clearly associated with
short-term complications, ranging from pyrogenic reactions to
septicaemia.6,7 Furthermore, microbial contamination of dialysis
fluid is an important cause of chronic inflammation and MIA syn-
drome (malnutrition, inflammation, and atherosclerosis) among
end-stage renal disease patients. Long-term HD patients suffer
from arteriosclerosis, and b2-microglobulin-associated amyloido-
sis with complicating spinal stenosis, carpal tunnel syndrome,
bone cysts and arthropathy. To overcome the above- mentioned
short and long-term complications of microbiologicallycontaminated dialysis fluid, the use of ultrapure dialysis fluid
(UPDF) which has a lower microbial load was recommended. This
has been accompanied by an improvement in the inflammatory
state of HD patient.8
The Association for the Advancement of Medical Instrumenta-
tion (AAMI) and the European Pharmacopoeia (EP) established
upper limits for microbial contamination of UPDF as containing
<0.1 colony forming unit (CFU)/ml and <0.03 endotoxin unit
(EU)/ml using LAL assay.9 To produce highly purified (ultrapure)
water, a system is required based on having a second reverse
osmosis (RO) module and/or an electrochemical deionizer (DI)
placed in series.10 There are no international standards for fungi
in dialysis fluids, however Fresenius Medical Care (FMC) recom-
mended the level of fungi to be <10 CFU/ml in dialysis water and
dialysis fluid, and <1 CFU/ml in UPDF.112. Aim of the work
This study aimed at evaluating microbial contamination of dia-
lysate and UPDF through estimation of heterotrophic plate count,
total coliforms and fungi as well as endotoxin detection.3. Material and methods
This cross-sectional study was carried out during a 6-months
period, on a total of 100 dialysis fluid samples randomly collected
from a private HD center in Alexandria, Egypt. The HD unit consists
of one water treatment unit and two rooms for HD. In this unit,
water passes through a RO filter and a mixed bed DI, and then it
is stored in a tank of 1000 Liter capacity. The finally treated water
is pumped into two rooms of HD through a system of polyvinyl
chloride (PVC) pipes to reach every HD machine. Chlorination is
done every month for maintenance of water treatment unit and
the bacterial filter (0.2 mm) is substituted every month. The total
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first room is back to back to the water treatment unit and contains
three machines. On the other hand, there is a long distance (about
20 m) between the water treatment unit and the second room
which contains five machines. Most of the machines were com-
mercial type A, the remaining were type B which is relatively
newer version with some technological advances. The dialysate
concentrate used in this unit is a sealed sterile capsulated bicar-
bonate powder along with the complementary solution A for bicar-
bonate based HD (referred to as A-component). Chemical
disinfection of machines is done after every session using 0.2% per-
acetic acid solution 30 min at room temperature.
3.1. Sampling
A total of eighty UPDF (infusate) samples were collected from
all online hemodiafiltration (HDF) sessions. In addition, twenty
pure dialysis fluid samples (distributed as 10 dialysis water and
10 final dialysate samples) were collected on weekly basis. Sam-
ples were aseptically collected in sterile wide-mouthed glass con-
tainers (1000 ml containers for infusate samples, 900 ml each, and
500 ml containers for dialysis fluid samples, 300 ml each).12
Thirty UPDF samples were collected from room (1) and 50 sam-
ples from room (2), out of which, 10 samples were from Type B
machine.
Before collecting the final treated water samples (dialysis
water), the faucets were wiped with alcohol, left to dry and then
water was left to flow for one minute to flush any residuals in
the connections and pipes. The final dialysate and the infusate fluid
samples were collected from sampling ports by allowing the fluid
to flow for half a minute then aseptically collected in glass contain-
ers. The samples for endotoxin analysis were collected aseptically
by one ml depyrogenated sterile disposable syringes.
All the collected samples were labeled, transported and deliv-
ered to the laboratory as soon as possible to be analyzed within
1–2 h of collection. In case of expected delay, samples were stored
at 4 C and analyzed within 24 h maximum. Each sample was
accompanied by a sheet including: sampling date, time of collec-
tion, sampling site and type of machine. All samples (dialysis
water, final dialysate and infusate) were subjected to membrane
filtration method, the membranes were plated onto the following
media: Reasoner’s 2A (R2A) agar (Oxoid CM0906), Eosine Methy-
lene Blue agar (EMB) (Levine CM0069) and Sabouraud dextrose
agar (SDA) (Oxoid CM0041) supplemented with 50 mg chloram-
phenicol/liter). R2A, a low nutrient medium used for the recovery
of stressed heterotrophic bacteria found in high purity water,
was used as recommended for HPC, and EMB was used for detec-
tion of total coliforms while SDA was used for fungal cultivation.
R2A and SDA plates were incubated at room temperature (25 C)
for at least 5 days and up to 7 days, while EMB plates were incu-
bated at 37 C for 24 h. After the incubation period, colonies were
counted and reported as CFU per ml of sample. LAL assay for endo-
toxin measurement was done by gel clot method, with PyrotellTable 1
Distribution of the acceptability of the 100 HD fluids samples according to the examined
Parameter
examined
Infusate samples (80) Dialysat
Standard Acceptable Standard
No. %
HPC <0.1 CFU/ml 63 78.8 <100 CFU
LAL <0.03 EU/ml 28 35.0 <0.25 EU
TC Zero 80 100.0 Zero
Fungi <1 CFU/ml 80 100.0 <10 CFU
Total acceptability 23 28.8(Associates of Cape Cod, Inc.) of sensitivities 0.25 EU/ml and 0.03
EU/ml for pure and ultrapure water samples respectively.
During the sessions in which samples were collected observa-
tion of any febrile/ pyrogenic reactions in patients were recorded.
3.2. Statistical analysis
Data were fed to the computer and analyzed using IBM SPSS
software package version 20.0. Qualitative data were described
using number and percent. Quantitative data were described using
range (minimum and maximum), mean, standard deviation and
median. Significance of the obtained results was judged at the 5%
level.
4. Results
During the time of sample collection, none of the HD patients
encountered any febrile/pyrogenic reaction.
According to the European standards for HD fluids and Frese-
nius Medical Care (FMC) guidelines 11,13 the final treated water
and the final dialysate were considered unacceptable if one or
more of the following criteria were found: HPC > 100 CFU/ml, pres-
ence of coliforms, endotoxin level > 0.25 EU/ml and fungi > 10 CFU/
ml. On the other hand, the infusate was considered unacceptable if
one or more of the following criteria were found: HPC > 0.1 CFU/
ml, presence of coliforms, endotoxin level > 0.03 EU/ml or fungi
> 1 CFU/ml.
According to the above standards, TC and fungi parameters
were found acceptable in all samples (100.0% each). Out of 80 infu-
sate samples, 63 samples (78.8%) were acceptable when examined
for HPC alone. The percentage of acceptability decreased to 35.0%
when examined by LAL alone and further decreased to 28.8% when
collectively evaluated by all parameters (Table 1).
The mean count of HPC was recorded for the infusate samples
as 0.09 ± 0.11 CFU/ml, and for dialysate and dialysis water samples
as (16.8 ± 2.39, and 23.0 ± 2.54 CFU/ml, respectively). Nearly equal
mean counts of fungi were present in infusate, dialysate and dial-
ysis water samples (0.05 ± 0.09, 0.04 ± 0.02 and 0.05 ± 0.04 CFU/ml
respectively), and all were within acceptable levels (Table 1).
Concerning the two types of HDmachines included in the study,
the mean count of fungi of infusate samples from Type A machines
was higher than that from Type B (0.05 ± 0.10, 0.02 ± 0.01 CFU/ml)
respectively. However, the difference was statistically insignificant
(p = 0.329). On the other hand, infusate samples from Type A
machines had significantly higher mean HPC counts than
those from Type B (0.09 ± 0.12, 0.02 ± 0.02 CFU/ml) respectively
(z = -3.60, p = 0.000⁄).
Out of 70 samples from Type A machines, 18 (25.7%) were
acceptable and 52 (74.3%) were unacceptable for endotoxin by
LAL testing. On the other hand, all the 10 samples from Type B
machine were acceptable by LAL, and this difference between both
machines as regards LAL testing was found to be statistically
significant (p = 0.000) Table 2.microbiological parameters.
e samples (10) Dialysis water samples (10)
Acceptable Standard Acceptable
No. % No. %
/ml 10 100.0 <100 CFU/ml 10 100.0
/ml 9 90.0 <0.25 EU/ml 10 100.0
10 100.0 Zero 10 100.0
/ml 10 100.0 <10 CFU/ml 10 100.0
9 90.0 10 100.0
Table 2
Distribution of infusate samples according to HD machine type and LAL acceptability.





No. % No. %
Type A 70 18 25.7 52 74.3 0.000*
Type B 10 10 100.0 0 0.0
p: p value of Fisher’s exact test.
* Statistically significant at p  0.05.
Table 3
Acceptability of samples from Type A machines according to HPC and LAL parameters and its relation to the total working hours of dialysis machines.
Total working hours Examined samples (78)** Acceptable samples for HPC Acceptable samples for LAL
No. % No. %
<5000 29 23 79.3 15 51.7
5000–10,000 40 32 80.0 9 22.5
>10,000 9 6 66.7 1 11.1
Test of significance (v2) 0.799 8.641
(P- value) 0.671 0.013*
* Statistically significant at p  0.05.
** 78 = 70 infusate and 8 dialysate samples.
Table 4




<0.03 EU/ml >0.03 EU/ml
Acceptable 23 40 63
Unacceptable 5 12 17
Total 28 52 80
Observed agreement: 0.44, Z = 0.96.
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machines were compared in both rooms. There was an insignifi-
cant difference between Room 1 and Room 2 as regards HPC and
fungal counts (HPC: 0.08 ± 0.06 CFU/ml and 0.11 ± 0.14 CFU/ml
respectively, fungal count: 0.07 ± 0.13 CFU/ml and 0.04 ± 0.08
CFU/ml respectively). However, Room 1 showed higher percentage
of acceptable infusate samples from Type A machines by LAL test
(53.3%) than Room 2 (5%) with statistical significance (v2 = 20.96,
p = 0.000).
About 80% of samples from Type A machines with a total
working hours <5000 or 5000–10,000 were acceptable for HPC
compared to 66.7% of samples from machines with >10,000 h.
However, this difference was statistically insignificant. On the
other hand, when examined by LAL, the percentages of acceptabil-
ity decreased to 51.7% and 22.5% for the machines with total work-
ing hours <5000 and 5000–10,000 respectively, compared to 11.1%
for those with >10,000 h. This difference was statistically signifi-
cant ((v 2 = 8.6, p = 0.013) (Table 3).
Out of the 80 infusate samples, 63 samples were acceptable by
HPC, and only 23 of these were also acceptable by LAL (Table 4).
The observed agreement between both parameters (HPC and
LAL) was 44%.
5. Discussion
The quality of the dialysate is of paramount importance in
assuring patient safety. To help prevent injury to HD patients from
contaminants in the dialysate, standards have been developed for
the quality of the dialysate as well as the water concentrates and
devices used in its preparation 13.Several studies reported the presence of microbiological con-
taminants in dialysate 14-18; however, data on ultrapure contami-
nation are infrequently available. In the present study, although
the acceptability for infusate was poor regarding both HPC and
LAL assay parameters, the respective acceptability for treated
water as well as dialysate was almost 100.0%. This can be explained
by the more astringent standard for the infusate. This high stan-
dard was not feasible to be accomplished by the older machine
technology (type A) which was of less technological advances.
Whereas recent advances in machine technology (type B) could
compensate for any potential defect in water treatment unit rais-
ing the acceptability of the infusate again to 100.0%.
In this study, the observed discrepancy between LAL assay and
HPC parameter agrees with reports of Klein et al.14 Kulander et al.15
and Bland et al.16 who found no correlation between bacterial
growth and endotoxin concentrations in water or dialysate sam-
ples. They proposed that low levels of bacterial growth in the dia-
lysate might be associated with high endotoxin concentration,
since endotoxin is released mainly after death of microorganisms.
Ledebo and Nystard recommended that endotoxin levels should
always be measured in addition to bacterial counts because they
give a different yet complementary picture of the microbiological
quality of the fluid.17
Regarding final dialysate, the present study revealed 100.0%
acceptability for HPC, while El-Koraie et al. reported lower compli-
ance results (51.7% and 86.1% acceptability at two HD units in
Alexandria).18 The AAMI/ISO standards recommend culturing con-
ditions that more closely resemble the conditions under which
contaminating bacteria exist in the systems used to prepare dialy-
sate. These new culturing conditions have been shown to increase
the yield of bacteria obtained for a given water or dialysate sample,
thus providing better information on the level of contamination in
the system.9,19 The above mentioned culturing conditions have
been implemented in the current study. In addition, the MF
method is also recommended by the AAMI/ISO standards and has
been implemented in this study for detecting low levels of
contamination.
There are few reports concerning the extent of fungal contami-
nation of dialysis fluid. Figel et al.20 isolated black fungi from the
municipal supply and in treated water for dialysis and dialysate.
Most of the international standards do not include fungi as
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rent standards for fungi are 10 CFU/ml.20 In this piece of work, no
fungal elements above the standard level were recorded.
In this study, TC were not isolated in any of the samples, where
dialysate concentrate used in this unit is a sealed sterile capsulated
bicarbonate powder (ready-made Bicart capsules). However, in a
previous study conducted in Alexandria, TC were isolated from
4% of examined samples, where reconstituted bicarbonate powder
was used, which is more liable for contamination. In that same
study, one sample was contaminated with E. coli, but neither TC
nor E. coli were revealed from the unit that was using ready-made
Bicart capsules.18 Again, Zunino et al.21 encountered TC in 0.5% of
samples whereas Arvanitidou et al.22 reported much higher
results: 12.3% for TC and 8.6% for E. coli.
Water purification by a double RO module is recommended,
because microbiological water quality after purification with a sin-
gle RO does not often comply with the reference quality level.2,4
The presence of a treated water-storage tank, as in the current
study, which may not be frequently drained and disinfected, is a
recognized factor contributing to persistent bacterial contamina-
tion and to biofilm formation.6,9 Favero et al. stated that storage
tanks should not be used unless provision were made for frequent
draining and adequate disinfection.23 Concerning the distribution
system, high grade stainless steel is the only material resistant to
biological corrosion.10 However, PVC is usually used because of
its low cost, as in this studied dialysis unit.
In the present study, infusate samples were collected from two
dialysis rooms, the first (room 1) is back to back to the water treat-
ment unit, while for the second room, long distribution tubes were
encountered (about 20 m long). This could explain the reason for
the much higher percentage of acceptable LAL infusate samples
at room 1 than room 2 (53.3% and 5.0% respectively). In addition,
HPC mean counts of infusate samples collected from dialysis
machines at room 2 were higher than those at room 1 (0.11 and
0.08 CFU/ml respectively), although did not reach a significant
level. These data indicate that dialysis fluid pathways should be
configured in a loop, be as short as possible, have no dead-ends,
and contain the minimum number of pipe fittings and joints.9,19
Otherwise, biofilm formation is frequently encountered in such
points, allowing the shedding of bacteria in low counts and the
continuous release of their degradation products, as the
endotoxins.
Regarding the finally treated water, the present study revealed
a 100.0% HPC acceptability. There was a significant association
between the quality of final dialysate and that of treated water.
Similarly, a study conducted by El-Koraie et al.18 showed an asso-
ciation between the final dialysate and each treated water and con-
centrates in the two examined HD units. In contrast, Baumbauer
et al.24 found no correlation between the level of contamination
of dialysate and the water processing method or type of
concentrate.
Arvantidou et al.22 suggested that the increasing working hours
of dialysis machines correlated more with the quality of dialysate,
as it becomes more difficult to clean or disinfect. In accordance
with those workers, the present study has shown significant
decrease of acceptability for LAL parameter with the increase of
the total working hours of the Type A machines.
Pertaining to HD machines, this study demonstrated significant
differences between Type A and Type B machines in the mean
counts of HPC and in LAL test results of infusate samples. This
might be related to the fact that Type B machine is of newer gen-
eration which incorporates recent technology regarding continu-
ous flow of dialysis fluid, the heating system and avoidance of
closed circuits and loops. Of note, that the back filter in the Type
B machine is a double filter bath (diasafe), whereas in the Type A
machine it is only single (foreclean filter). New machines haveincorporated several recommended features including low vol-
umes of hydraulic circuit, high dialysate rates, global disinfection
and non stagnant zones.10
Fortunately, despite the detection of endotoxin levels that were
more than the permissible one (0.03 EU/ml), there were no
encountering of any pyrogenic reactions among patients on HDF
sessions. This could be considered as potential limitation, as the
main aim of this study did not address clinical signs for endotox-
emia and inflammatory reactions, which can be further investi-
gated in future research. However, this issue was previously
tackled in assessing endotoxin level in HD patients and its role in
inducing inflammation.25 Di Iorio et al. reported after a one year
study of using ultrafilter, C-reactive protein and pro-inflammatory
cytokines decreased while anti-inflammatory ones increased, and
hemoglobin levels were improved. They speculated that ultrapure
water can ameliorate the inflammatory status and improve sur-
vival of dialysis patients.26
The present study has shown 44% agreement between HPC and
LAL parameters performed to assess the quality of the infusate. The
same percentage of agreement was reported by El-Koraie et al. in
Alexandria.18 On further analysis of our findings, HPC showed
21.2% unacceptability, which increased to 65.0% and 71% by LAL
and by both HPC and LAL respectively. In accordance with these
findings, El-Koraie et al. revealed that HPC showed 40.0% unaccept-
ability, which increased to 88.0% and 92.0% by LAL and by both HPC
and LAL respectively.18
6. Conclusion
This study highlighted the potential risk and safety concern that
might be associated with the use of online HDF if to be generalized
without implementing the international microbiological standards
for ultrapure dialysate quality. Again, the ability to reach a 100.0%
acceptability of the infusate using the more advanced newer HDF
machines can raise the hope of implementing such technique with
a high safety margin. It is also evident that long distribution tubes
in the HD unit, as well as long working hours of HD machines, are
of paramount importance in determining the quality of infusate
used in online HDF.
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